LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1

被引：0
|
作者：
Qi-Hua Chen
Bo Li
De-Guo Liu
Biao Zhang
Xian Yang
Ya-Ling Tu
机构：
[1] Hunan University of Chinese Medicine,Department of Andrology, The First Hospital
[2] Hunan University of Chinese Medicine,Graduate School
[3] Hunan University of Chinese Medicine,Department of Dermatology, The First Hospital
来源：
Cancer Cell International | / 20卷
关键词：
Prostate cancer; KCNQ1OT1; MiR-15a; PD-L1; Immune evasion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] LncRNA IFITM4P promotes immune escape by up-regulating PD-L1 via dual mechanism in oral carcinogenesis
    Shi, Linjun
    Yang, Yuquan
    Li, Mengying
    Li, Chenxi
    Zhou, Zengtong
    Tang, Guoyao
    Wu, Lan
    Yao, Yilin
    Shen, Xuemin
    Hou, Zhaoyuan
    Jia, Hao
    MOLECULAR THERAPY, 2022, 30 (04) : 1564 - 1577
  • [22] LncRNA KCNQ1OT1 facilitates the progression of bladder cancer by targeting MiR-218-5p/HS3ST3B1
    Yongzhi Li
    Benkang Shi
    Fengming Dong
    Xingwang Zhu
    Bing Liu
    Yili Liu
    Cancer Gene Therapy, 2021, 28 : 212 - 220
  • [23] LncRNA KCNQ1OT1 facilitates the progression of bladder cancer by targeting MiR-218-5p/HS3ST3B1
    Li, Yongzhi
    Shi, Benkang
    Dong, Fengming
    Zhu, Xingwang
    Liu, Bing
    Liu, Yili
    CANCER GENE THERAPY, 2021, 28 (3-4) : 212 - 220
  • [24] PKCα inhibitors promote breast cancer immune evasion by maintaining PD-L1 stability
    Yu, Jiaojiao
    Xiang, Yujin
    Gao, Yuzhen
    Hua, Fang
    Zhang, Xiaowei
    Li, Pingping
    Cui, Bing
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 771 - 772
  • [25] PKCa inhibitors promote breast cancer immune evasion by maintaining PD-L1 stability
    Yu, Jiaojiao
    Xiang, Yujin
    Gao, Yuzhen
    Chang, Shan
    Kong, Ren
    Lv, Xiaoxi
    Yu, Jinmei
    Jin, Yunjie
    Li, Chenxi
    Ma, Yiran
    Wang, Zhenhe
    Zhou, Jichao
    Yuan, Hongyu
    Shang, Shuang
    Hua, Fang
    Zhang, Xiaowei
    Cui, Bing
    Li, Pingping
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (10) : 4378 - 4395
  • [26] RETRACTED: KCNQ1OT1 accelerates gastric cancer progression via miR-4319/DRAM2 axis (Retracted Article)
    Wang, Jijun
    Wu, Fan
    Li, Yaoyao
    Pang, Lei
    Wang, Xiaohong
    Kong, Guimei
    Zhang, Tong
    Yu, Duonan
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2020, 34
  • [27] KCNQ1OT1 promotes ovarian cancer progression via modulating MIR-142-5p/CAPN10 axis
    Liu, Hongli
    Chen, Ruixin
    Kang, Fenhong
    Lai, Haiqing
    Wang, Yanlong
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (02):
  • [28] LncRNA PROX1-AS1 Facilitates Gastric Cancer Progression via miR-877-5p/PD-L1 Axis
    Guo, TianWei
    Wang, Wei
    Ji, YueXia
    Zhang, Min
    Xu, GuoYing
    Lin, Sen
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2669 - 2680
  • [29] TFDP3 promotes the immune escape by up-regulating the expression of PD-L1 on breast cancer cells
    Zhang, Y.
    Lin, Y.
    Zheng, X.
    Yao, Y.
    Song, Y.
    Huang, T.
    Liu, K.
    Han, Z.
    Chu, M.
    Wang, Y.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1546 - 1546
  • [30] LncRNA KCNQ1OT1 attenuates myocardial injury induced by hip fracture via regulating of miR-224-3p/GATA4 axis
    Duan, Xuzhou
    Miao, Zhijing
    Chen, Jia
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 107
12345